BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants
BIOLASE MAINTAINS MOMENTUM AND REPORTS NINTH CONSECUTIVE QUARTER OF YEAR-OVER-YEAR GROWTH; REITERATES FULL YEAR GUIDANCE OF AT LEAST 25% REVENUE GROWTH AND PROFITABILITY FOR FULL YEAR 2023
Biolase Investor Presentation
Q1 2023 Financial Results Conference Call
Sign Up For Email Alerts
Receive updates straight into your inboxSign up today
Reducing Fear and Anxiety Related to Dentistry
BIOLASE, Inc. is a medical device company and global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and surgical applications. BIOLASE's laser systems are designed to provide clinically superior, patient friendly results for many types of common dental procedures compared to those achieved with traditional instruments. BIOLASE has sold over 45,500 laser systems to date in over 80 countries around the world.
BIOLASE, Inc. at a Glance
Laser systems sold (in more than 80 countries)
Approximate Patented and patent-pending technologies
Net Revenues by Category
Sales by End Market
Net Revenues by Region
For complete information regarding our financials, see our periodic filings.
27042 Towne Centre Drive
Foothill Ranch, CA 92610-2811
EVC Group LLC
EVC Group LLC
Computershare Trust Company, N.A.